Fig. 2From: Concurrent chemoradiotherapy with conventional fractionated radiotherapy and low-dose daily cisplatin plus weekly docetaxel for T2N0 glottic cancerCause-specific (solid dotted) and progression-free (solid line) survival from the start of treatmentBack to article page